Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b8941a241dbb854dd3d18d897b3836f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1843219e8aa9e5ed41121f93cf2cb531 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
filingDate |
2012-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a29cf5f26e5fe6dc12568aacd398df7 |
publicationDate |
2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2013026454-A1 |
titleOfInvention |
Treatment of clinical conditions with anthracyclines |
abstract |
The invention relates to pharmaceutical compositions comprising an anthracycline for the treatment of disease of the prostate including prostate cancer, prostatitis and benign prostate hyperplasia, an inflammatory bladder disease or for treatment of metastasis. The compositions are in general prepared for direct administration to the site of disease. The anthracycline is an anthracycline, which does not induce necrosis and/or lasting tissue damage upon application to skin of human beings, for example valrubicin. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11367872-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11114662-B2 |
priorityDate |
2011-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |